Cargando…
Renocardiovascular Biomarkers: from the Perspective of Managing Chronic Kidney Disease and Cardiovascular Disease
Mortality among the patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) remains high because of the very high incidence of cardiovascular disease (CVD) such as coronary artery disease, cardiac hypertrophy, and heart failure. Identifying CVD in patients with CKD/ESRD remains...
Autores principales: | Niizuma, Shinichiro, Iwanaga, Yoshitaka, Yahata, Takaharu, Miyazaki, Shunichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337832/ https://www.ncbi.nlm.nih.gov/pubmed/28321399 http://dx.doi.org/10.3389/fcvm.2017.00010 |
Ejemplares similares
-
Cathepsin S As an Inhibitor of Cardiovascular Inflammation and Calcification in Chronic Kidney Disease
por: Sena, Brena F., et al.
Publicado: (2018) -
Circulating Biomarkers for Cardiovascular Disease Risk Prediction in Patients With Cardiovascular Disease
por: Wong, Yuen-Kwun, et al.
Publicado: (2021) -
Trajectory of low-density lipoprotein cholesterol in patients with chronic kidney disease and its association with cardiovascular disease
por: Wang, Shih-Wei, et al.
Publicado: (2022) -
Anemia of Chronic Disease in Patients With Cardiovascular Disease
por: Lanser, Lukas, et al.
Publicado: (2021) -
Sortilin as a Biomarker for Cardiovascular Disease Revisited
por: Møller, Peter Loof, et al.
Publicado: (2021)